Cost Analysis: Port Delivery System versus Monthly Ranibizumab for Wet Age-Related Macular Degeneration Treatment

Overview of attention for article published in Ophthalmology Retina, May 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 2,419 followers.

RT @Nemo_Patel_MD: Cost analysis of port delivery vs intravitreal injection of ranibizumab @AAOjournal @HaseninAl https://t.co/Nml5nqJ…

Cost analysis of port delivery vs intravitreal injection of ranibizumab @AAOjournal @HaseninAl https://t.co/Nml5nqJFHE

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.